Patent application number | Description | Published |
20090048217 | 17Beta-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE - The 17β-cyano-19-nor-androst-4-ene derivatives of the present invention possess gestagenic activity. They have the general chemical formula 1, in which Z is selected from the group comprising O, two hydrogen atoms, NOR and NNHSO | 02-19-2009 |
20100292184 | 17BETA-CYANO-19-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE - The 17β-cyano-19-androst-4-ene derivatives of the present invention possess gestagenic activity. They have the general chemical formula 1, in which Z is selected from the group comprising O, two hydrogen atoms, NOR and NNHSO | 11-18-2010 |
20100317632 | 17-(1'PROPENYL)-17-3'-OXIDOESTRA-4-EN-3-ONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE - The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R | 12-16-2010 |
20110003779 | 15, 16-METHYLENE-17-(1'-PROPENYL)-17,3'-OXIDOESTRA-4-EN-3-ONE DERIVATIVE , USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE - The invention relates to 15,16-methylene-17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the Z, R | 01-06-2011 |
20110015162 | 15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative - The invention relates to 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivatives with the general chemical formula I, and R | 01-20-2011 |
20110021472 | 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID Y-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE - The invention relates to 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivatives with the chemical formula I, where R | 01-27-2011 |
20110218340 | 2-[1-Cyanopropyl)Carbamoyl]-5-Chloromethyl Nicotinic Acids and the Use Thereof in Manufacturing Herbicidal Imidazolinones - 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids of formula (I) where Z is hydrogen or halogen; Z | 09-08-2011 |
20110224433 | Process for Manufacturing Substituted 3-pyridylmethyl Ammonium Bromides - A process for manufacturing 5,6-disubstituted-3-pyridylmethyl ammonium bromides (I), | 09-15-2011 |
20110224439 | Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides - A process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides (I) | 09-15-2011 |
20110245505 | Process for Manufacturing 5-Formyl-Pyridine-2,3-Dicarboxylic Acid Esters - A process for manufacturing a 5-formyl-pyridine-2,3-dicarboxylic acid ester (I) wherein Z is hydrogen or halogen; Z | 10-06-2011 |
20130005985 | Process Using Grignard Reagents - The present invention relates to a process using Grignard reagents for providing thio-triazolo group-containing compounds. | 01-03-2013 |
20130096312 | Process for Preparing 4-hydroxypyridines - The present invention relates to a process for preparing 4-hydroxypyridines of formula I | 04-18-2013 |
20130123219 | 19-NOR-STEROID DERIVATIVES WITH A 15a,16a-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES - The 15α,16α-methylene-17-hydroxy-19-nor-17-pregna-4-en-3-one-21-carboxylic acid γ-lactone derivatives of the present invention possess progestational efficacy. They have the general chemical formula I, in which Z is selected from the group comprising an oxygen atom, two hydrogen atoms, NOR and NNHSO | 05-16-2013 |
20140206873 | Process for Manufacturing 5-Chloromethyl-2,3-Pyridine Dicarboxylic Acid Anhydrides - A process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides (I) | 07-24-2014 |
20140206884 | Process Using Grignard Reagents - The present invention relates to a process using Grignard reagents for providing thio-triazolo group-containing compounds. | 07-24-2014 |